Name: Biodesix, Inc. (BDSX) Financial Statements
Creator: FinSpry

Biodesix Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Biodesix, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	71.32	49.09	38.21	54.51	45.56
Cost of Revenue	15.57	13.01	14.15	30.52	22.00
Gross Profit	55.75	36.08	24.06	23.99	23.56
Operating Expenses
Research & Development	9.56	9.99	13.10	12.79	10.82
Selling, General & Administrative	80.45	67.39	61.46	50.52	34.86
Operating Expenses	90.01	77.38	74.56	95.45	68.49
Operating Income	-34.26	-41.30	-50.51	-40.94	-22.93
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00
Interest Expense	-8.26	9.54	-8.07	-4.51	-7.60
Other Income/Expense	0.07	-1.31	0.19	-2.31	0.86
Income
Income Before Tax	-42.93	-52.15	-65.45	21.14	14.23
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-42.93	-52.15	-65.45	-43.16	-31.35
Net Income - Continuous Operations	-42.93	-52.15	-65.45	-43.16	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-28.49	-37.10	-46.91	-35.47	-20.84
EBIT	-34.26	-42.61	-50.51	-38.65	-23.75
Depreciation & Amortization	5.77	5.51	3.60	3.18	2.90
Earnings Per Share
Basic EPS	-7.00	-13.00	-31.00	-32.00	-6.00
Diluted EPS	-7.00	-13.00	-31.00	-2.00	-6.00
Basic Shares Outstanding	6.48	4.11	2.11	27.37	4.84
Diluted Shares Outstanding	6.48	4.11	2.11	27.32	4.84